BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer
The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.
The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.
CancerCare provides telephone, online and face-to-face counseling, support groups, education, publications and financial and co-payment assistance.
Read about why health and social care secretary Wes Streeting has launched a national investigation into NHS maternity services.
Learning disability nursing student programme Minnie Christensen talks about her experience of completing a programme that promotes leadership skills among nursing and allied healthcare professionals.
Jacqui Cooper on how nurses must be equipped with the knowledge and skills to engage with AI technologies critically.
Discover how an improvement programme highlighted the widespread prescribing of psychotropic medications to children and young people in inpatient settings.
Breyanzi demonstrated a 95.5% response rate among patients with relapsed/refractory marginal zone lymphoma, as well as a durable safety.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
If there is ever an annual follow up CT scan that does not cause me significant anxiety, this year will be the one.
I became a colon cancer survivor after my 2020 diagnosis, and I share how my scars, mindset shifts and journaling helped me embrace this second…
A study explores how prior authorization requirements; coverage stoppages and other red tape can generate barriers to life saving therapies in cancer care.